ArticleFrontiers in pharmacology2024

KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine.

Wei Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.